0001209191-23-014157.txt : 20230301 0001209191-23-014157.hdr.sgml : 20230301 20230301164842 ACCESSION NUMBER: 0001209191-23-014157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230227 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szymanska Anna CENTRAL INDEX KEY: 0001804499 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 23694431 MAIL ADDRESS: STREET 1: C/O MARKER THERAPEUTICS, INC. STREET 2: 3200 SOUTHWEST FREEWAY, SUITE 2240 CITY: HOUSTON STATE: TX ZIP: 77027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-27 0 0001094038 Marker Therapeutics, Inc. MRKR 0001804499 Szymanska Anna C/O MARKER THERAPEUTICS, INC. 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 0 1 0 0 Vice President, Quality Employee Stock Option (right to buy) 2.14 2023-02-27 4 A 0 29947 0.00 A 2033-02-27 Common Stock 29947 29947 D This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. /s/ Michael Loiacono, Attorney-in-Fact 2023-03-01